filmov
tv
FIGARO-DKD Trial Results
Показать описание
Investigator Bertram Pitt recaps the results of FIGARO-DKD.
0:04:44
FIGARO-DKD Trial Results
0:03:59
ESC TV at #ESCCongress 2021 - FIGARO-DKD
0:14:25
Insights from the FIGARO-DKD and FIDELIO-DKD trials - English Language - Dr. Gawad
0:26:55
Dr. Rajeev Agrawal - Insights from the FIDELIO-DKD and FIGARO-DKD Trial
0:07:22
FIGARO: Where will finerenone fit into diabetic kidney disease treatment | David Wheeler
0:53:59
Finerenone e CKD: FIDELIO-DKD Trial
0:05:45
ESC 2022: FIDELITY: Finerenone in Pts With Chronic Kidney Disease | Prof Gerasimos Filippatos
0:03:21
FIDELIO DKD Results
0:04:00
Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD
0:03:07
Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials
0:07:20
La SEC te lleva a ESC21 [IN] ∙ FIGARO-DKD Trial
0:54:16
Effects of canagliflozin versus finerenone on cardiorenal outcomes
0:02:03
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
0:13:59
FIDELIO-DKD, CREDENCE-like outcomes
0:34:04
George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
0:05:07
Finerenone, a non-steroidal MRA
0:20:59
Novel Treatment Options for CKD in Type 2 Diabetes – Evaluating Latest Landmark Trial Results
0:58:13
KDIGO 2023 CKD Guideline: Evaluation, Prognostication, and Management of Kidney Disease
0:01:54
Effect of Finerenone on Chronic Kidney Disease Outcomes in T
0:18:00
DKD treatment update: SGLT2 inhibitors and finerenone | Ian de Boer & Amrit Lamba
2:04:39
Kidney Week 2020 Reimagined: High-Impact Clinical Trials Presentations
0:05:00
La SEC te lleva a HF21 [IN] ∙ FIDELIO-DKD Trial
0:24:43
JC 14 april PARI finerenone
0:56:20
Finerenone Investor-Webinar
Комментарии